Search research articles
Contact Us
Filters
Showing results (131-140 of 140) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 140 results.
Cancer Treatment Reports
|
March 1, 1986
Metalloporphyrin contrast agents for magnetic resonance imaging of human tumors in mice
N J Patronas, J S Cohen, R H Knop, et al.
International Journal of Cancer
|
November 15, 1988
Comparative studies on the expression of tumor-associated glycoprotein (TAG-72), CA 19-9 and DU-PAN-2 in normal, benign and malignant pancreatic tissue
H Takasaki, M A Tempero, E Uchida, et al.
Diseases of the Colon and Rectum
|
October 1, 1987
Radioimmunoguided surgery using the monoclonal antibody B72.3 in colorectal tumors
B J Sickle-Santanello, P J O'Dwyer, C Mojzisik, et al.
European Journal of Nuclear Medicine
|
June 18, 1998
In vivo evaluation of a lead-labeled monoclonal antibody using the DOTA ligand
D E Milenic, M Roselli, M W Brechbiel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 1, 1997
Patient-specific dosimetry of indium-111- and yttrium-90-labeled monoclonal antibody CC49
P K Leichner, G Akabani, D Colcher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 1, 1992
Phase I trial of iodine-131-chimeric B72.3 (human IgG4) in metastatic colorectal cancer
R F Meredith, M B Khazaeli, W E Plott, et al.
American Journal of Surgery
|
November 1, 1988
Radioimmunoguided surgery using monoclonal antibody
E W Martin, C M Mojzisik, G H Hinkle, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 8, 2001
Outpatient treatment with (131)I-anti-B1 antibody: radiation exposure to family members
F J Rutar, S C Augustine, D Colcher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2000
Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer
S J Knox, M L Goris, M Tempero, et al.
Nuclear Medicine and Biology
|
June 10, 1998
Immunolymphoscintigraphy in breast cancer: evaluation using 131I-labeled monoclonal antibody B72.3
L M Fig, R S Brown, L von Moll, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 140) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 140 results.
Cancer Treatment Reports
|
March 1, 1986
Metalloporphyrin contrast agents for magnetic resonance imaging of human tumors in mice
N J Patronas, J S Cohen, R H Knop, et al.
International Journal of Cancer
|
November 15, 1988
Comparative studies on the expression of tumor-associated glycoprotein (TAG-72), CA 19-9 and DU-PAN-2 in normal, benign and malignant pancreatic tissue
H Takasaki, M A Tempero, E Uchida, et al.
Diseases of the Colon and Rectum
|
October 1, 1987
Radioimmunoguided surgery using the monoclonal antibody B72.3 in colorectal tumors
B J Sickle-Santanello, P J O'Dwyer, C Mojzisik, et al.
European Journal of Nuclear Medicine
|
June 18, 1998
In vivo evaluation of a lead-labeled monoclonal antibody using the DOTA ligand
D E Milenic, M Roselli, M W Brechbiel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 1, 1997
Patient-specific dosimetry of indium-111- and yttrium-90-labeled monoclonal antibody CC49
P K Leichner, G Akabani, D Colcher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 1, 1992
Phase I trial of iodine-131-chimeric B72.3 (human IgG4) in metastatic colorectal cancer
R F Meredith, M B Khazaeli, W E Plott, et al.
American Journal of Surgery
|
November 1, 1988
Radioimmunoguided surgery using monoclonal antibody
E W Martin, C M Mojzisik, G H Hinkle, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 8, 2001
Outpatient treatment with (131)I-anti-B1 antibody: radiation exposure to family members
F J Rutar, S C Augustine, D Colcher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2000
Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer
S J Knox, M L Goris, M Tempero, et al.
Nuclear Medicine and Biology
|
June 10, 1998
Immunolymphoscintigraphy in breast cancer: evaluation using 131I-labeled monoclonal antibody B72.3
L M Fig, R S Brown, L von Moll, et al.
Page
of 14